Lung cancer, the No. 1 cancer mortality rate, differs by gender, and studies show that the quality of a man's lung cancer is worse. In addition, 9 out of 10 lung cancer patients do not experience smoking, so other measures are needed to prevent female lung cancer. Recently, the Korean Lung Cancer Society, together with the Central Cancer Registry, published the results of an epidemiological study on lung cancer in Korea. To date, national lung cancer statistics for sex, age and 5-year survival rates of lung cancer patients have only been published. In this study, the common characteristics of Korean lung cancer patients can be examined by examining smoking history, sexual characteristics, symptoms, treatment behavior, and survival rate by stage and therapy. The Society followed 2621 of the 2,960 lung cancers registered in 52 hospitals across the country in 2014 and followed it up to December 2017.
Woman has lung cancer, even if the woman does not experience lifelong smokingLung cancer patients 36. patients Patients never smoke. Three to four in 10 people have lung cancer even if they haven't been drinking their whole life. Specifically, 16% of male lung cancer patients and 87.5% of female patients were heavily absent in the history of smoking. The most common symptoms of lung cancer were cough (35.4%), sputum (21.6%), dyspnea (20.4%), and pain (19.7%) and 13.8% asymptomatic.
Male lung cancer had a poorer prognosis than female lung cancer. Smoking is one of the main reasons. Kim Young-ta, president of Seoul National University Hospital, Department of Thoracic and Cardiovascular Surgery, says, "The back is very fatal, develops rapidly, and spreads well, while with few symptoms and good treatment, adenocarcinoma progresses slowly. " In the case of adenocarcinoma, there are several targeted therapies that are effective. Therefore, survival is higher in male lung cancer patients compared with female lung cancer patients with adenocarcinoma.Ra Graphic. The average survival is 19.5 months for men and 28.7 months for women. "Lung cancer among smokers, even among women, is the same predictor of lung cancer among male smokers," said Choi Chang-min, a professor of respiratory medicine at Asan Medical Center in Seoul.
In addition, female lung cancer patients are more likely to convert oncogenes called EGFRs compared to male patients (.22.2% in women and 6.6.6% in men). Better. The median survival of patients with EGFR gene mutations is 18 months, longer than patients with genetic mutations (8 months).
Half of patients with lung cancer occur in the fourth
Seventy-five percent of lung cancer patients were diagnosed in stage 4. In the end the findings revealed that only only..6% of the patients had surgery, .3.33% had received radiation therapy and 2.1% had CCRT. Most cancers require surgery before they are treated. Half of the patients appear in the fourth stage, and they do not have surgery. "There is no proper screening method," Choi Chang-min said.
Kim Yung-chul, chair of the Lung Cancer Registration Committee at Hsun Jeonam National University Hospital, said that smoking of lung cancer patients is not yet conducted in an appropriate manner, but blood tests, bronchial tests, etc. are not conducted on an experimental basis. Professor Choi Chang-min said, "If you are over 50, you are recommended to take a low dose CT."
ન Non-smoker lung cancer than Koreans and Westerners
Lung Cancer US in Korean And non-smoker lung cancer is more common in Europe. Professor Choi Chang-min said, "I do not know the exact cause, but it is believed that there is a genetic tendency for weak lung cancer."
On the other hand, the factors that exacerbated lung cancer prognosis were male, old age, lifetime smoking, low BMI, low routine ability and high stage.